In phase-2 trials, the drug was given to 50 patients aged 15 years and older with relapsed or refractory B-cell leukaemia or B-cell lymphoma. The typical age of the overall study group was 44 years.

Destiny 2’s pinnacle PVP activity, Trials of Osiris, returns yet again. If you want to know what this week’s featured map and weapon are, we have all that and more in this breakdown of the ...

The men’s and women’s course records tumbled at the Zurich Barcelona Marathon on Sunday (16) with Tesfaye Deriba Ketema and Sharon Chelimo winning the World Athletics Gold Label road race in 2:04:13 ...

There is emerging interest in adaptive platform trials for inflammatory bowel disease. In this Comment, we present the results of a workshop that was convened to consider the opportunities and ...

In the world you will have tribulation. But take heart; I have overcome the world." (John 16:33) Read powerful Bible verses about trials and tribulations to find encouragement and solace in the Word ...

Trial results show vepdegestrant, a protein-degrading drug Arvinas is developing with Pfizer, improved on fulvestrant in a subgroup of breast cancer patients, but not the overall study population.

Ethiopia's Tesfaye Deriba and Kenya's Sharon Chelimo won the men's and women's titles at the 2025 Barcelona Marathon, respectively, on Sunday, 16 March. Both runners broke the course record in their ...